Free Trial

Genenta Science (GNTA) Short Interest Ratio & Short Volume

Genenta Science logo
$5.45
+0.35 (+6.86%)
(As of 11/1/2024 ET)

Genenta Science Short Interest Data

Genenta Science (GNTA) has a short interest of 11,600 shares. This marks a 152.17% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 10,385 shares to cover all short positions.

Current Short Interest
11,600 shares
Previous Short Interest
4,600 shares
Change Vs. Previous Month
+152.17%
Dollar Volume Sold Short
$67,280.00
Short Interest Ratio
0.9 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
18,220,000 shares
Percentage of Shares Shorted
0.06%
Today's Trading Volume
6,175 shares
Average Trading Volume
10,385 shares
Today's Volume Vs. Average
59%
Short Selling Genenta Science?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genenta Science and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNTA Short Interest Over Time

GNTA Days to Cover Over Time

GNTA Percentage of Float Shorted Over Time

Genenta Science Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202411,600 shares $67,280.00 +152.2%N/A0.9 $5.80
9/30/20244,600 shares $19,642.46 -20.7%N/A0.3 $4.27
9/15/20245,800 shares $22,910.00 -40.8%N/A0.5 $3.95
8/31/20249,800 shares $37,926.00 -18.3%N/A0.8 $3.87
8/15/202412,000 shares $52,200.00 -14.9%N/A1.1 $4.35
7/31/202414,100 shares $60,628.59 +227.9%N/A1.2 $4.30
7/15/20244,300 shares $14,878.00 +4.9%N/A0.3 $3.46
6/30/20244,100 shares $12,710.00 -18.0%N/A1 $3.10
6/15/20245,000 shares $16,186.50 +47.1%N/A1.2 $3.24
5/31/20243,400 shares $11,662.00 +79.0%N/A0.6 $3.43
5/15/20241,900 shares $6,080.00 -60.4%N/A0.3 $3.20
4/30/20244,800 shares $14,784.00 +23.1%N/A0.8 $3.08
4/15/20243,900 shares $13,123.50 +30.0%N/A0.7 $3.37
3/31/20243,000 shares $10,500.30 -9.1%N/A0.7 $3.50
3/15/20243,300 shares $12,870.00 -5.7%N/A0.8 $3.90
2/29/20243,500 shares $15,399.65 -5.4%N/A1.2 $4.40
2/15/20243,700 shares $14,800.00 +5.7%N/A1.3 $4.00
1/31/20243,500 shares $14,105.00 -5.4%N/A1.3 $4.03
1/15/20243,700 shares $16,465.00 No ChangeN/A1.8 $4.45
12/31/20233,700 shares $18,315.00 -32.7%N/A1.7 $4.95
12/15/20235,500 shares $27,610.00 +14.6%N/A2.5 $5.02
11/30/20234,800 shares $23,760.00 -35.1%N/A2.4 $4.95
11/15/20237,400 shares $38,480.00 +37.0%N/A3.9 $5.20
10/31/20235,400 shares $28,836.00 -25.0%N/A3.2 $5.34
10/15/20237,200 shares $40,248.00 +1.4%N/A3.8 $5.59
9/30/20237,100 shares $36,565.00 +10.9%N/A4.4 $5.15
9/15/20236,400 shares $36,032.00 -1.5%N/A3.6 $5.63
8/31/20236,500 shares $37,700.00 -17.7%N/A3.2 $5.80
8/15/20237,900 shares $43,687.00 +9.7%N/A3.4 $5.53
7/31/20237,200 shares $39,168.00 +50.0%N/A3 $5.44
7/15/20234,800 shares $28,560.00 -14.3%N/A2.2 $5.95
6/30/20235,600 shares $32,984.00 +7.7%N/A2.7 $5.89
6/15/20235,200 shares $29,848.00 +300.0%N/A2.4 $5.74
5/31/20231,300 shares $7,932.73 -23.5%N/A0.5 $6.10
5/15/20231,700 shares $9,537.00 +54.6%N/A0.7 $5.61
4/30/20231,100 shares $6,600.00 +266.7%N/A0.4 $6.00
4/15/2023300 shares $1,890.00 No ChangeN/A0.1 $6.30
3/31/2023300 shares $1,725.00 -40.0%N/A0.1 $5.75
3/15/2023500 shares $3,350.00 -66.7%N/A0.1 $6.70
2/28/20231,500 shares $9,750.00 +114.3%N/A0.3 $6.50
We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
2/15/2023700 shares $4,585.00 -22.2%N/A0.2 $6.55
1/31/2023900 shares $5,526.00 -50.0%N/A0.2 $6.14
1/15/20231,800 shares $11,610.00 -30.8%N/A0.4 $6.45
12/30/20222,600 shares $14,300.00 +116.7%N/A0.6 $5.50
12/15/20221,200 shares $6,780.00 +140.0%N/A0.4 $5.65
11/30/2022500 shares $2,605.00 -80.8%N/A0.2 $5.21
11/15/20222,600 shares $10,816.00 +225.0%N/A1.2 $4.16
10/31/2022800 shares $3,520.00 +33.3%N/A0.4 $4.40
10/15/2022600 shares $2,742.00 -25.0%N/A0.3 $4.57
9/30/2022800 shares $3,983.92 -11.1%N/A0.3 $4.98
9/15/2022900 shares $4,719.33 +125.0%N/A0.3 $5.24
8/31/2022400 shares $2,368.00 -71.4%N/A0.1 $5.92
8/15/20221,400 shares $8,876.00 -12.5%N/A0.4 $6.34
7/31/20221,600 shares $10,512.00 -46.7%N/A0.3 $6.57
7/15/20223,000 shares $20,220.00 No ChangeN/A0.6 $6.74

GNTA Short Interest - Frequently Asked Questions

What is Genenta Science's current short interest?

Short interest is the volume of Genenta Science shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 11,600 shares of GNTA short. Learn More on Genenta Science's current short interest.

What is a good short interest ratio for Genenta Science?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNTA shares currently have a short interest ratio of 1.0. Learn More on Genenta Science's short interest ratio.

Is Genenta Science's short interest increasing or decreasing?

Genenta Science saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 11,600 shares, an increase of 152.2% from the previous total of 4,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Genenta Science's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genenta Science: Taysha Gene Therapies, Inc. (10.10%), Voyager Therapeutics, Inc. (6.33%), MeiraGTx Holdings plc (2.74%), Alpha Teknova, Inc. (3.02%), Akebia Therapeutics, Inc. (8.41%), Cryoport, Inc. (5.91%), Zevra Therapeutics, Inc. (9.56%), Amylyx Pharmaceuticals, Inc. (2.45%), YS Biopharma Co., Ltd. (0.20%), Jasper Therapeutics, Inc. (15.63%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Genenta Science stock?

Short selling GNTA is an investing strategy that aims to generate trading profit from Genenta Science as its price is falling. GNTA shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genenta Science?

A short squeeze for Genenta Science occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNTA, which in turn drives the price of the stock up even further.

How often is Genenta Science's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNTA, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:GNTA) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners